Serum soluble B7-H4 was found to be associated with poor outcomes and overall survival of renal cancer patients, and it has been proposed for predicting the prognosis of patients with non-metastatic clear cell renal cell carcinoma [22]. The gene discussed is VTCN1; the disease is renal carcinoma.